Utilities, Consumer...
Health Care: Health Services
Abiomed Inc. (ABMD: NASDAQ)
$23.19 -0.36 | -1.53%
02/09/12 - 04:00 PM ET
821.31K / 303.40K
Vol / Avg. Vol:23.79 / 23.55
Open / Prev. Close:23.19 - 23.85
Today's Range:9.98 - 23.67
52 Wk Range:27.50%
Performance YTD:TheStreet Rating:
Portfolios with ABMD
- Portfolio NameUser Type
- ContributorStocks Rising On Unusual Vo...
- Contributor10 Top Morningstar M&A Stoc...
- ContributorStocks Rising On Unusual Vo...
- ContributorStocks At New 52-Week Highs...
- ContributorTop Stocks of the 10 Best M...
- UserPART 6 JPMorgan 28th Annual...
- User52 week high 52 week low
- UserRAPTOR SPRTD-1102091914
- UserPART 5 JPMorgan 27th Annual...
- Userblackcat Portfolio 1
Latest ABMD Headlines from TheStreet
- Abiomed Rises On Unusually High Volume (ABMD) 02.08.12 | 03:02 pm
- Abiomed Stock Falls On Unusually High Volume (ABMD) 02.07.12 | 12:02 pm
- Abiomed Reaches New 52-Week High (ABMD) 02.06.12 | 11:02 am
- 8 Stocks Soaring on Unusual Volume 02.03.12 | 04:02 pm
- Abiomed Stock Gaps Up On Today's Open (ABMD) 02.03.12 | 08:02 am
- 10 Top Morningstar M&A Stock Picks for 2012 01.20.12 | 01:01 pm
- 6 Stocks at New 52-Week Highs 12.13.11 | 01:12 pm
- Abiomed Stock Hits New 52-Week High (ABMD) 12.09.11 | 12:12 pm
- Abiomed Stock Hits New 52-Week High (ABMD) 11.30.11 | 10:11 am
- Abiomed Stock Hits New 52-Week High (ABMD) 11.04.11 | 01:11 pm
Press Releases for ABMD
- Abiomed Reports Record Revenue Of $32.2 Million And Earnings Of $2.9 Million For Third Quarter Of Fiscal 2012 - Business Wire 02.03.12 | 07:02 am
- New Clinical Data For Symphony Presented In Late Breaking Clinical Trials Session At The Society Of Thoracic Surgeons 2012 Annual Meeting - Business Wire 01.31.12 | 08:01 am
- Abiomed Third Quarter Fiscal 2012 Earnings And Conference Call Notification - Business Wire 01.26.12 | 12:01 pm
- Abiomed 2011 Investor Day Webcast Replay Available - Business Wire 12.12.11 | 09:12 am
- Abiomed Announces Expanded Heart Recovery Strategy With Multi Year Growth Initiatives - Business Wire 12.09.11 | 02:12 pm
- Abiomed To Release New Data And Product Updates At Investor & Analyst Day On December 9 - Business Wire 12.07.11 | 04:12 pm
- Catheterization And Cardiovascular Interventions Journal Publishes Results From USpella Registry - Business Wire 11.28.11 | 07:11 am
- Abiomed To Present At Piper Jaffray 23rd Annual Healthcare Conference - Business Wire 11.21.11 | 01:11 pm
- (Graphic: Business Wire) - Business Wire 11.14.11 | 11:11 am
- Abiomed Announces Schedule Of Events At American Heart Association 2011 Scientific Sessions - Business Wire 11.11.11 | 05:11 pm
Partner Headlines for ABMD
- Abiomed Tops, Swings to Black - Analyst Blog - Zacks 02.06.12 | 09:02 am
- Wunderlich Maintains Buy, $24 Target on Abiomed - Benzinga 12.12.11 | 09:12 am
- Abiomed Raised to Outperform - Analyst Blog - Zacks 11.11.11 | 07:11 pm
- Zacks #1 Rank Additions for Monday - Tale of the Tape - Zacks 11.07.11 | 09:11 am
- Neutral View on Abiomed - Analyst Blog - Zacks 08.16.11 | 06:08 pm
- Healthcare Stocks in the News on Tuesday - Seeking Alpha 06.29.11 | 09:06 am
- UPDATE 1-US FDA warns Abiomed on marketing of heart pump - Reuters 06.28.11 | 11:06 am
- Cramer's Mad Money - 6 Earnings to Watch in the Coming Week (6/3/11) - Seeking Alpha 06.05.11 | 06:06 am
- Reaffirming Abiomed at Neutral - Analyst Blog - Zacks 05.23.11 | 07:05 pm
- Abiomed Beats on Impella Boost - Analyst Blog - Zacks 05.19.11 | 07:05 pm
